Evidence
Document this CPD
Add to Google Keep
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Psychiatry goes psychedelic
🌐 90 Days
VR Related Evidence Matrix
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Psychiatric risks for worsened mental health after psychedelic use
- Psychedelic-assisted therapy for people with gambling disorder?
- Adolescent Psychedelic Use and Psychotic or Manic Symptoms
- RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
- Is it now time to prepare psychiatry for a psychedelic future?
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness
- PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress
- Toad psychedelic points to biological target for antidepressants
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- Mechanisms of therapeutic change after psychedelic treatment in OCD
- Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA)
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD)
- Balance and Change in Forensic Psychiatry
- The child psychiatry pioneer who approached ADHD in a new way
- Free expression and open discourse in Australasian Psychiatry
- Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats
- Research Letter: The state of academic psychiatry in Aotearoa New Zealand and Australia: Data from a survey of the Royal Australian and New Zealand College of Psychiatrists membership
- From Bytes to Insights: The Promise and Peril of Artificial Intelligence-Powered Psychiatry
- The Future of General Psychiatry Must Include Autism Spectrum Disorder and Intellectual Disability
- An empty bliss beyond this world - the music of The Caretaker as a representation of dementia - Psychiatry in music
- Advancing Diversity, Equity, and Inclusion at JAMA Psychiatry
- A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder
- A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder
- Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD)
- Bridging the Gap: Psychiatry's Role in the New Era of Obesity Treatment
- Editorial: Reviews in psychiatry 2022: forensic psychiatry
- A Curriculum on Digital Psychiatry for a US-Based Psychiatry Residency Training Program: Pilot Implementation Study
- A Curriculum on Digital Psychiatry for a US-Based Psychiatry Residency Training Program: Pilot Implementation Study
- Forensic Psychiatry Education in Child and Adolescent Psychiatry (CAP) Fellowship: Results from a Multi-site Survey
- Exploring the impact of trauma-adapted yoga in forensic psychiatry
- Child & Adolescent Mental Health Seminar Series: 'Genetics and a family-based approach in psychiatry'
- Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms
- The Role of Psychiatry for Transgender and Gender Diverse Adults
- The Role of Psychiatry for Transgender and Gender Diverse Adults
- Knowledge and attitudes towards eating disorders: A survey of psychiatrists and psychiatry trainees in New South Wales
- SCNi Prize Medal lecture: 'Multidimensional sleep health: From concept to clinic'
- N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk
- In vitro and in vivo metabolism of psilocybin's active metabolite psilocin
- In vitro and in vivo metabolism of psilocybin's active metabolite psilocin
- A case series of musical hallucinations in psychiatry of old age-in search of the sound of silence
- The Effects of Ayahuasca on Psychological Disorders: A Systematic Literature Review
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine
- Ethics and law in the application of new technology in forensic psychiatry
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine
- Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial
- Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial
- Suicide prevention: reflections on progress over the past decade
- Suicide prevention: reflections on progress over the past decade
- Suicide prevention: reflections on progress over the past decade
- Lived experience and family engagement in psychiatry research: A scoping review of reviews
- Munchausen Syndrome in the Context of Liaison Psychiatry: A Case Report and a Narrative Review
- Implementing patient-reported outcome measures on an adolescent inpatient psychiatry unit: A feasibility study
- Off-label prescribing of psychotropics in a psychiatric patient population in Australia
- Validating the knowledge represented by a self-organizing map with an expert-derived knowledge structure
- Study Highlights Key Predictors of Adolescent Substance Use; Special Issue of the American Journal o
- Commentary: Early intervention for conduct problems as a child protection strategy - reflections on Nobakht et al. (2023)
Evidence Blueprint
Psychiatry goes psychedelic
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Psychiatry goes psychedelic
🌐 365 Days
VR Related Evidence Matrix
- Psychedelia: The interplay of music and psychedelics
- The bodily self from psychosis to psychedelics
- Psychedelic Therapy: A Primer for Primary Care Clinicians-The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
- Longitudinal associations between psychedelic use and psychotic symptoms in the United States and United Kingdom
- THC-O-Acetate: Scarce Evidence for a Psychedelic Cannabinoid
- Extended difficulties following the use of psychedelic drugs: A mixed methods study
- Psychedelic therapy in the treatment of addiction: the past, present and future
- Psychiatric risks for worsened mental health after psychedelic use
- Psychedelic-assisted therapy for people with gambling disorder?
- Adolescent Psychedelic Use and Psychotic or Manic Symptoms
- Psychedelic use and psychiatric risks
- Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility
- Psychedelic Microdosing among Young Adults from Southern California
- The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits
- Older adults in psychedelic-assisted therapy trials: A systematic review
- Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics
- RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine
- Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations
- Is it now time to prepare psychiatry for a psychedelic future?
- Public interest in psilocybin and psychedelic therapy in the context of the COVID-19 pandemic: A Google Trends analysis
- Psychedelics and neonihilism: connectedness in a meaningless world
- Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
- Group psychedelic therapy: empirical estimates of cost-savings and improved access
- Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives
- The Intricate Interaction Between Expectations and Therapeutic Outcomes of Psychedelic Agents
- PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients
- Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness
- The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics
- Psychedelics reopen the social reward learning critical period
- Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review
- 5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study
- PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION
- Cardiovascular safety of psychedelic medicine: current status and future directions
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- Neuroimaging correlates of classical psychedelics effects: A systematic review
- The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
- Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects
- Exploring the subjective experience of rave party participants in Israel who consume psychedelic drugs: a qualitative inquiry
- Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress
- Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain
- Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models
- Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders
- Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
- Phytochemical interventions for post-traumatic stress disorder: A cluster co-occurrence network analysis using CiteSpace
- Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study
- Toad psychedelic points to biological target for antidepressants
- An ancient psychedelic for traumatic brain injury
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Psychedelic Therapy-A New Paradigm of Care for Mental Health
- Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study
- Tripping outside the lines: lessons from observational studies of combination psychedelic use beyond regulated clinical contexts
- Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans
- Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans
- In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
- Mechanisms of therapeutic change after psychedelic treatment in OCD
- Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD)
- Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
- Bedside to bench: the outlook for psychedelic research
- Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice
- Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA)
- Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
- Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico
- Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy